Resources from the same session
365MO - Exploring changes in glioblastoma treatment patterns in Europe and the USA with population-based cancer registry data
Presenter: Francesco Giusti
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
366MO - Incidence of malignant and non-malignant CNS tumours in Hong Kong
Presenter: Ka Man Cheung
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
367MO - Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective, observational study
Presenter: Lidia Gatto
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
368MO - Fatty acid synthase inhibitor TVB-2640 with bevacizumab in recurrent glioblastoma
Presenter: William Kelly
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
369MO - Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)
Presenter: Marta Padovan
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
370MO - FOLAGLI: A phase I study of folinic acid combined with temozolomide and radiotherapy to modulate MGMT gene promoter methylation in newly diagnosed MGMT non-methytated glioblastoma
Presenter: Jean-Sebastien Frenel
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
371MO - Usefulness of circulating tumour DNA detection from cerebrospinal fluid in recurrent high-grade glioma
Presenter: Maxime Fontanilles
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
372MO - Melanoma leptomeningeal metastases: A European multicenter cohort
Presenter: Emilie Le Rhun
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
373MO - Delivery and activity of SN-38 by sacituzumab govitecan in CNS tumours
Presenter: Andrew Brenner
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
Invited Discussant 365MO, 366MO and 367MO
Presenter: Matthias Preusser
Session: Mini Oral - CNS
Resources:
Slides
Webcast